Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.

Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial. J Am Coll Cardiol. 2003 Apr 16; 41(8):1251-60.

View in: PubMed

subject areas

Adult
Aged
Blood Flow Velocity
Coronary Angiography
Coronary Circulation
Drug Administration Schedule
Drug Therapy, Combination
Female
Fibrinolytic Agents
Heart Conduction System
Humans
Injections, Intravenous
Male
Middle Aged
Myocardial Infarction
Peptides
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Tissue Plasminogen Activator
Treatment Outcome

authors with profiles

Robert Harrington